• #357993
  • 288
  • Merck #00006489700

PedvaxHIB® Haemophilus Influenzae Type b Vaccine (Hib) Indicated for People 2 to 71 Months of Age 7.5 mcg / 0.5 mL Injection Single-Dose Vial 0.5 mL

PEDVAXHIB, VL 0.5ML (10/BX)

Merck 00006489700
PedvaxHIB® Haemophilus Influenzae Type b Vaccine (Hib) Indicated for People 2 to 71 Months of Age 7.5 mcg / 0.5 mL Injection Single-Dose Vial 0.5 mL
Compare
Features
  • Each 0.5 mL dose of Liquid PedvaxHIB is a sterile product formulated to contain: 7.5 mcg of Haemophilus b PRP, 125 mcg of Neisseria meningitidis OMPC and 225 mcg of aluminum as amorphous aluminum hydroxyphosphate sulfate (previously referred to as aluminum hydroxide), in 0.9% sodium chloride, but does not contain lactose or thimerosal
  • More …
  Log In to Order
or
 View Alternatives

Product Specifications

Features
  • Each 0.5 mL dose of Liquid PedvaxHIB is a sterile product formulated to contain: 7.5 mcg of Haemophilus b PRP, 125 mcg of Neisseria meningitidis OMPC and 225 mcg of aluminum as amorphous aluminum hydroxyphosphate sulfate (previously referred to as aluminum hydroxide), in 0.9% sodium chloride, but does not contain lactose or thimerosal
More Information

Professionals Also Viewed

  • #1028203
  • 153
  • Glaxo Smith Kline #58160081811
Hiberix® Haemophilus Influenzae Type b Vaccine (Hib) Indicated for People 6 Weeks Through 4 Years of Age 10 mcg / 0.5 mL Injection Single-Dose Vial 0.5 mL
  • HIBERIX is a vaccine indicated for active immunization for the prevent …
  • HIBERIX is approved for use in children 6 weeks through 4 years of age …
  • 10 single dose vials of lyophilized vaccine
  • #1026991
  • 412
  • Sanofi Pasteur #545-03
ActHIB® Haemophilus Influenzae Type b Vaccine (Hib) Indicated for People 2 Months to 5 Years of Age 10 mcg / 0.5 mL Injection Single-Dose Vial 0.5 mL
  • ActHIB is a vaccine indicated for the prevention of invasive disease c …
  • ActHIB vaccine is approved for use as a four dose series in infants an …
Compare Products (0) Clear Compare